Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2012; 18(22): 2837-2843
Published online Jun 14, 2012. doi: 10.3748/wjg.v18.i22.2837
Table 2 Laboratory features including tumor markers in serum and ascites of the patients
Tuberculous peritonitis(n = 27)Peritoneal carcinomatosis(n = 25)P value
Serum lab
Serum WBC (/mm3)6083.7 ± 3115.96429.6 ± 2466.6NS
Serum lymphocyte (%)16.70 ± 8.39 22.01 ± 7.190.02
Serum CRP (mg/dL)7.88 ± 6.623.12 ± 2.690.03
Serum CEA (ng/mL)1.79 ± 1.0910.26 ± 25.380.02
Serum CA 19-9 (U/mL)10.63 ± 8.522283.56 ± 6211.990.05
Serum CA 125 (U/mL)591.36 ± 440.95676.73 ± 1088.28NS
Ascites lab
Ascites WBC (/mm3)1325.9 ± 955.1951.1 ± 773.1NS
Ascites lymphocyte (%)67.77 ± 23.4148.36 ± 18.78< 0.01
Ascites albumin (g/dL)2.30 ± 0.752.32 ± 0.76NS
SAAG0.72 ± 0.491.05 ± 0.500.03
Ascites ADA (IU/L)66.76 ± 32.09 13.89 ± 8.95< 0.01
Ascites CEA (ng/mL)1.36 ± 0.83682.77 ± 1955.340.01
Ascites CA 19-9 (U/mL)17.53 ± 24.1512344.10 ± 33569.78NS
Ascites CA 125 (U/mL)1069.20 ± 578.741188.56 ± 1439.06NS